Analysts putting the weights on merck........re keytruda....
I keep repeating this but those last patent approvals are vital in these
combos......
https://www.google.com/url?sa=t&source=web&cd=1&ved=2ahUKEwig1Zbwx63gAhVGX30KHZHfA14QFjAAegQIBhAB&url=http%3A%2F%2Fwww.pmlive.com%2Fpharma_news%2Fanalysts_look_beyond_keytruda_in_mercks_future_1277223&usg=AOvVaw0_VtqlGf3MBswLskJ74nIx
if keytruda and efti prove compatible and positive it will extend keytruda's
patent period in certain cancer treatments by some 8-10 years....
Given they are making some $2.2B per quarter from keytruda alone
it's not hard to work out the possibilities if "EFTI" plays its part.
Analysts putting the weights on merck........re keytruda....I...
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
28.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $486.6M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 42858 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.5¢ | 2000 | 1 |
View Market Depth
| Last trade - 09.27am 22/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |
Day chart unavailable
